XML 40 R40.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Segment Reporting and Foreign Operations (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Segment Reporting [Abstract] |
Schedule of Long-lived Assets by Geographic Area | Our long-lived assets (which are comprised of our net property, plant and equipment) by geographic area at December 31, 2019, 2018 and 2017, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2019 |  | 2018 |  | 2017
United States | ​ | $ | 273,816 | ​ | $ | 231,864 | ​ | $ | 202,504
Ireland | ​ |  | 44,912 | ​ |  | 45,283 | ​ |  | 45,671
Other foreign countries | ​ |  | 60,057 | ​ |  | 54,305 | ​ |  | 44,645
Total | ​ | $ | 378,785 | ​ | $ | 331,452 | ​ | $ | 292,820
Schedule of Segment Reporting Information, by Segment | Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2019, 2018 and 2017, are as follows (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2019 |  | 2018 |  | 2017
Net Sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 960,981 | ​ | $ | 849,477 | ​ | $ | 700,613
Endoscopy | ​ |  | 33,871 | ​ |  | 33,276 | ​ |  | 27,239
Total net sales | ​ |  | 994,852 | ​ |  | 882,753 | ​ |  | 727,852
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Expenses | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cardiovascular | ​ |  | 382,313 | ​ |  | 321,461 | ​ |  | 281,095
Endoscopy | ​ |  | 34,619 | ​ |  | 14,692 | ​ |  | 12,089
Total operating expenses | ​ |  | 416,932 | ​ |  | 336,153 | ​ |  | 293,184
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Income | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 25,780 | ​ |  | 49,289 | ​ |  | 24,819
Endoscopy | ​ |  | (10,346) | ​ |  | 9,328 | ​ |  | 8,250
Total operating income | ​ |  | 15,434 | ​ |  | 58,617 | ​ |  | 33,069
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other income (expense) - net | ​ |  | (13,241) | ​ |  | (9,098) | ​ |  | 2,812
Income tax expense (benefit) | ​ |  | (3,258) | ​ |  | 7,502 | ​ |  | 8,358
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 5,451 | ​ | $ | 42,017 | ​ | $ | 27,523
​ Total assets by business segment at December 31, 2019, 2018 and 2017, consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2019 |  | 2018 |  | 2017
Cardiovascular | ​ | $ | 1,745,057 | ​ | $ | 1,588,970 | ​ | $ | 1,103,806
Endoscopy | ​ |  | 12,264 | ​ |  | 31,042 | ​ |  | 8,005
Total | ​ | $ | 1,757,321 | ​ | $ | 1,620,012 | ​ | $ | 1,111,811
Total depreciation and amortization by business segment for the years ended December 31, 2019, 2018 and 2017 consisted of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2019 |  | 2018 |  | 2017
Cardiovascular | ​ | $ | 91,151 | ​ | $ | 68,722 | ​ | $ | 52,700
Endoscopy | ​ |  | 949 | ​ |  | 824 | ​ |  | 882
Total | ​ | $ | 92,100 | ​ | $ | 69,546 | ​ | $ | 53,582
​ Total capital expenditures for property and equipment by business segment for the years ended December 31, 2019, 2018 and 2017 consisted of the following (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2019 |  | 2018 |  | 2017
Cardiovascular | ​ | $ | 77,631 | ​ | $ | 63,032 | ​ | $ | 38,437
Endoscopy | ​ |  | 542 | ​ |  | 292 | ​ |  | 186
Total | ​ | $ | 78,173 | ​ | $ | 63,324 | ​ | $ | 38,623
Reconciliation of Assets from Segment to Consolidated | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2019 |  | 2018 |  | 2017
Net Sales | ​ | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 960,981 | ​ | $ | 849,477 | ​ | $ | 700,613
Endoscopy | ​ |  | 33,871 | ​ |  | 33,276 | ​ |  | 27,239
Total net sales | ​ |  | 994,852 | ​ |  | 882,753 | ​ |  | 727,852
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Expenses | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cardiovascular | ​ |  | 382,313 | ​ |  | 321,461 | ​ |  | 281,095
Endoscopy | ​ |  | 34,619 | ​ |  | 14,692 | ​ |  | 12,089
Total operating expenses | ​ |  | 416,932 | ​ |  | 336,153 | ​ |  | 293,184
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Operating Income | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 25,780 | ​ |  | 49,289 | ​ |  | 24,819
Endoscopy | ​ |  | (10,346) | ​ |  | 9,328 | ​ |  | 8,250
Total operating income | ​ |  | 15,434 | ​ |  | 58,617 | ​ |  | 33,069
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other income (expense) - net | ​ |  | (13,241) | ​ |  | (9,098) | ​ |  | 2,812
Income tax expense (benefit) | ​ |  | (3,258) | ​ |  | 7,502 | ​ |  | 8,358
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 5,451 | ​ | $ | 42,017 | ​ | $ | 27,523

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration